ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Arlevert:Zambon Svizzera SA
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
N07CA52 - Cinnarizine, CombinationsATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N07 - Other Nervous System Drugs

This group comprises other nervous system drugs, which cannot be classified in the preceding 2nd levels in ATC group N.

N07C - Antivertigo Preparations

This group comprises agents mainly used in the treatment of vertigo.
See also:
A04A - Antiemetics and antinauseants
C04AX - Other peripheral vasodilators
N02C - Antimigraine preparations
N05A - Antipsychotics
R06A - Antihistamines for systemic use

The DDDs are based on treatment of vestibular symptoms.

N07CA - Antivertigo Preparations

Cinnarizine in combination with diphenhydramine teoclate or dihydroergocristine are classified in N07CA52.

The DDD for the N07CA52 refers to cinnarizine and is based on the combination of cinnarizine and diphenhydramine teoclate.

N07CA52 - Cinnarizine, Combinations
Concentr.Adm.RouteNote
 ORefers to cinnarizine
2025 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home